NIDA has reissued a Program Announcement, PA-18-773, International Research Collaboration on Drug Abuse and Addiction Research, which will be in effect until May 2021. The funding opportunity will support R01 research grant applications that:
NIDA has reissued its Program Announcements (PAs) soliciting collaborative research proposals between investigators from domestic U.S. institutions and researchers in other countries. The PAs—International Research Collaboration on Drug Abuse and Addiction Research—will be in effect until May 8, 2018. Researchers may choose one of three grant programs in response to these broad calls for innovative research proposals:
NIDA has committed $2 million in fiscal year (FY) 2014 to fund two to three awards for scientists who propose cutting-edge—and possibly transformative—approaches to major challenges in biomedical and behavioral research on HIV/AIDS that are relevant to drug abuse. Applications are due November 6, 2013. For more information, see RFA-DA-14-008
NIDA supports research on the biomedical and behavioral causes, consequences, prevention, and treatment of drug abuse and addiction. Learn how research is supported by reading the Introduction to Funding.
Although some international researchers receive NIDA support through a direct foreign grant, most international research is supported through a domestic grant with a foreign component, where a principal investigator from a U.S. institution works with a researcher from another country.
The National Institute on Drug Abuse (NIDA) intends to commit $4 million to fund 8 to 10 awards in fiscal year 2012 to support implementation science projects that will inform the President’s Emergency Program for AIDS Relief (PEPFAR) as it develops more efficient and cost-effective methods to deliver HIV prevention, treatment, and care for drug-using populations.
Recent awards through the NIDA International Program Announcements (PA) on International Research Collaboration on Drug Abuse and Addiction Research will support four research teams investigating drug-related HIV:
NIDA has reissued its Program Announcements (PAs) soliciting collaborative research proposals by U.S. investigators working with investigators from other countries. The PAs—International Research Collaboration on Drug Abuse and Addiction—will be in effect until January 8, 2015.
Researchers may choose one of three grant programs in response to these broad calls for innovative research proposals: R01, R21, or R03. Priority funding will be given to projects that are collaboratively funded by an agency of the foreign country. Research priority areas include: